These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 14699228

  • 1. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
    Tripathi M, Kaushik S, Dubey P.
    J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
    [Abstract] [Full Text] [Related]

  • 2. Vecuronium block in the myasthenic patient. Influence of anticholinesterase therapy.
    Baraka A, Taha S, Yazbeck V, Rizkallah P.
    Anaesthesia; 1993 Jul; 48(7):588-90. PubMed ID: 8102223
    [Abstract] [Full Text] [Related]

  • 3. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients.
    Mann R, Blobner M, Jelen-Esselborn S, Busley R, Werner C.
    Anesthesiology; 2000 Aug; 93(2):346-50. PubMed ID: 10910480
    [Abstract] [Full Text] [Related]

  • 4. Is the degree of sensitivity to nondepolarizing muscle relaxants related to requirements for postoperative ventilation in patients with myasthenia gravis?
    Kadoi Y, Hinohara H, Kunimoto F, Niijima A, Saito S, Goto F.
    Anaesth Intensive Care; 2004 Jun; 32(3):346-50. PubMed ID: 15264728
    [Abstract] [Full Text] [Related]

  • 5. Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases.
    McCreery KM, Hussein MA, Lee AG, Paysse EA, Chandran R, Coats DK.
    Binocul Vis Strabismus Q; 2002 Jun; 17(3):181-6. PubMed ID: 12171588
    [Abstract] [Full Text] [Related]

  • 6. [Therapy of myasthenia gravis with cholinesterase inhibitors--principles and pharmacologic monitoring].
    Henze T.
    Fortschr Neurol Psychiatr; 1996 Mar; 64(3):110-21. PubMed ID: 8900891
    [Abstract] [Full Text] [Related]

  • 7. Cisatracurium in a myasthenic patient undergoing thymectomy.
    Baraka A, Siddik S, Kawkabani N.
    Can J Anaesth; 1999 Aug; 46(8):779-82. PubMed ID: 10451139
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in respiratory condition after thymectomy for patients with myasthenia gravis.
    Mori T, Yoshioka M, Watanabe K, Iwatani K, Kobayashi H, Terasaki H, Kawasuji M.
    Ann Thorac Cardiovasc Surg; 2003 Apr; 9(2):93-7. PubMed ID: 12732085
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcomes of pediatric ocular myasthenia gravis.
    Ortiz S, Borchert M.
    Ophthalmology; 2008 Jul; 115(7):1245-1248.e1. PubMed ID: 18155768
    [Abstract] [Full Text] [Related]

  • 13. Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy.
    Muenster T, Forst J, Goerlitz P, Schmitt HJ.
    Paediatr Anaesth; 2008 Mar; 18(3):251-5. PubMed ID: 18230069
    [Abstract] [Full Text] [Related]

  • 14. [Myasthenia gravis in Santo Tomás Hospital 1990-1997].
    Frago G, Gracia F, Chang E, Andrade Alegre R.
    Rev Med Panama; 1998 Sep; 23(2):15-9. PubMed ID: 11214554
    [Abstract] [Full Text] [Related]

  • 15. Minimally invasive gastric bypass in a morbidly obese patient with myasthenia gravis.
    Schumann R, Tarnoff M, Siddiqui ZI.
    Obes Surg; 2004 Oct; 14(9):1273-6. PubMed ID: 15527647
    [Abstract] [Full Text] [Related]

  • 16. Graded response to thymectomy in children with myasthenia gravis.
    Tracy MM, McRae W, Millichap JG.
    J Child Neurol; 2009 Apr; 24(4):454-9. PubMed ID: 19339286
    [Abstract] [Full Text] [Related]

  • 17. [Current treatment of myasthenia gravis].
    de Assis JL.
    Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
    [No Abstract] [Full Text] [Related]

  • 18. [Rocuronium vs vecuronium for neuromuscular block during transsternal thymectomy in the patient with myasthenia gravis].
    Cordero Escobar I.
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):578-82. PubMed ID: 22263401
    [Abstract] [Full Text] [Related]

  • 19. The effect of neostigmine on pyridostigmine bioavailability in myasthenic patients after oral administration.
    Chan K, Davison SC, Dehghan A, Hyman N.
    Methods Find Exp Clin Pharmacol; 1981 Dec; 3(5):291-6. PubMed ID: 7329157
    [Abstract] [Full Text] [Related]

  • 20. [Serum levels of pyridostigmine in myasthenia gravis: methods and clinical significance].
    Schumm F, Gaertner HJ, Wiatr G, Dichgans J.
    Fortschr Neurol Psychiatr; 1985 Jun; 53(6):201-11. PubMed ID: 2991094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.